Relevant News

Researchers at Miguel Hernández University have successfully demonstrated the effectiveness of an innovative topical cream in reducing chemotherapy-induced peripheral neuropathy. The international clinical trial involving 142 cancer patients showed significant reduction in hand neuropathy incidence and delayed symptom onset during treatment.

Yale researchers have made breakthrough discoveries in targeting specific sodium channels (Nav1.8) in peripheral nerves. This new approach could offer the first major advancement in neuropathic pain treatment in over four decades, providing hope for millions suffering from diabetic neuropathy, chemotherapy-induced neuropathy, and other chronic pain conditions.

University of Arizona researchers received a major National Cancer Institute grant to develop noninvasive confocal microscopy for examining nerve endings in cancer patients. This innovative approach could lead to objective biomarkers for chemotherapy-induced peripheral neuropathy, enabling earlier detection and personalized treatment approaches.

New research from the University of Michigan Health Lab reveals critical insights into how poor blood sugar control during teenage years significantly increases the risk of developing neuropathy in adulthood. This finding emphasizes the importance of early intervention and tight glucose control in young diabetic patients.